Batch Surveillance in Pharma 2026: Ultimate Guide to Ensuring Drug Safety & Compliance

Implementing solutions in batch surveillance minimizes errors and boosts speed.

Batch Surveillance in Pharma monitors released lots using complaints, OOS/OOT trends, and stability results to catch issues early. FDA expects deviation investigations under 21 CFR 211.192 and quality oversight aligned with 21 CFR 211.22. Strong surveillance improves traceability, limits recall scope, and supports global compliance when teams align procedures with FDA cGMP, ICH Q10/Q9 principles, and USP standards.